EUVIMEDEUVIMED entdecken
Open Access

Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy

Anny Reyes iD, Alena Stasenko, Austin Hopper, Jiwandeep S Kohli, Jonathan L Helm, Mia Salans, Divya Prabhakaran, Lily Kamalyan iD, Molly Wilkinson, Soumya Unnikrishnan, Roshan Karunamuni, Jona Hattangadi-Gluth iD und 1 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noae183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Anny Reyes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Cognitive Dysfunction, Glioma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Burroughs Wellcome Fund Postdoctoral Diversity Enrichment Program, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with primary brain tumors demonstrate heterogeneous patterns of cognitive dysfunction, which we explore using latent profile analysis to identify cognitive phenotypes and their trajectories in patients receiving radiotherapy (RT).

Methods

Ninety-six patients completed neuropsychological testing before and post-RT (3, 6, and 12 months) on a prospective longitudinal trial, including measures of processing speed, executive function, language, and verbal and visual memory. Models with 2–4 classes were examined. Demographic and clinical data were examined across phenotypes and post-RT cognitive change was evaluated.

Results

The optimal model identified 3 unique cognitive phenotypes including a group of patients with generalized impairments (11.5%), a group with isolated verbal memory impairments (21.9%), and a group with minimal impairments (66.7%). The Verbal Memory phenotype had fewer years of education (P = .007) and a greater proportion of males (P < .001); the Generalized group had a greater proportion of patients with IDH-wild type gliomas and showed greater symptoms of anxiety and poorer quality of life (P-values < .05); and the Minimal Impairment phenotype had higher rates of IDH-Mutant gliomas. Approximately 50% of patients declined on at least one cognitive domain with memory being the most vulnerable. Patients who declined reported greater symptoms of depression (P = .007) and poorer quality of life (P = .025).

Conclusions

We identified 3 distinct cognitive phenotypes in patients with primary brain tumors receiving RT, each associated with unique demographic and clinical (eg, IDH mutational status) profiles, with mood symptoms associated with late cognitive decline. This patient-centered approach enhances our understanding of clinical profiles associated with cognitive dysfunction and treatment-related neurotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCognitive DysfunctionGliomaHumansMaleFemaleMiddle AgedPhenotypeNeuropsychological TestsProspective StudiesAdultLongitudinal StudiesAgedQuality of LifeFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

cognitive declinememoryneurotoxicitypatient-centeredphenotypes

Autor:innen und Institutionen

  • Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California, USA.
  • Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
  • Department of Psychology, San Diego State University, San Diego, California, USA.
  • San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, California, USA.
  • Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA.
  • Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Anny Reyes, Lily Kamalyan, Jona Hattangadi-Gluth

Förderung

  • NCI NIH HHS
  • Burroughs Wellcome Fund Postdoctoral Diversity Enrichment Program
  • NINDS NIH HHS
  • National Academy of Neuropsychology Clinical Research
  • NIMH NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • HSRD VA

Zitieren

APA

Reyes, A., Stasenko, A., Hopper, A., Kohli, J. S., Helm, J. L., Salans, M., Prabhakaran, D., Kamalyan, L., Wilkinson, M., Unnikrishnan, S., Karunamuni, R., Hattangadi-Gluth, J., & McDonald, C. R. (2025). Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae183

Vancouver

Reyes A, Stasenko A, Hopper A, Kohli JS, Helm JL, Salans M, et al. Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy. Neuro-Oncology. 2025. doi:10.1093/neuonc/noae183

BibTeX
@article{Reyes2025,
  author = {Reyes, Anny and Stasenko, Alena and Hopper, Austin and Kohli, Jiwandeep S and Helm, Jonathan L and Salans, Mia and Prabhakaran, Divya and Kamalyan, Lily and Wilkinson, Molly and Unnikrishnan, Soumya and Karunamuni, Roshan and Hattangadi-Gluth, Jona and McDonald, Carrie R},
  title = {Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noae183}
}
Kostenlos starten →